Literature DB >> 2568378

Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics.

M J Rey1, P Schulz, C Costa, P Dick, R Tissot.   

Abstract

Chlorpromazine (CPZ) equivalents are often used as a relative measure of the antipsychotic potency of neuroleptics. We review the CPZ equivalents of 33 neuroleptics and illustrate why imprecisions or discrepancies will be difficult to eliminate from these values. We nevertheless underline that CPZ equivalents can be clinically useful, since they facilitate the choice of doses of different neuroleptics that should induce comparable antipsychotic effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568378     DOI: 10.1097/00004850-198904000-00001

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  39 in total

1.  Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge.

Authors:  I Grzella; B W Müller; R D Oades; S Bender; U Schall; D Zerbin; J Wolstein; G Sartory
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Prolactin-a biomarker for antipsychotic treatment response?

Authors:  Sri M Agarwal; Naren P Rao; Kapil Jhamnani; Ganesan Venkatasubramanian; Rishikesh V Behere; Shivarama Varambally; Bangalore N Gangadhar
Journal:  Prim Care Companion CNS Disord       Date:  2011

3.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

4.  Evaluation of Defined Daily Dose, percentage of British National Formulary maximum and chlorpromazine equivalents in antipsychotic drug utilization.

Authors:  Waleed M Sweileh; Jihad Bani Odeh; Naser Y Shraim; Sa'ed H Zyoud; Ansam F Sawalha; Samah W Al-Jabi
Journal:  Saudi Pharm J       Date:  2013-04-06       Impact factor: 4.330

5.  Gender effects on brain changes in early-onset psychosis.

Authors:  Marta Rapado-Castro; Cali F Bartholomeusz; Josefina Castro-Fornieles; Ana González-Pinto; Soraya Otero; Inmaculada Baeza; Carmen Moreno; Montserrat Graell; Joost Janssen; Nuria Bargalló; Christos Pantelis; Manuel Desco; Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-15       Impact factor: 4.785

6.  Dose Equivalents for Antipsychotic Drugs: The DDD Method.

Authors:  Stefan Leucht; Myrto Samara; Stephan Heres; John M Davis
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

7.  Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients.

Authors:  Berend Malchow; Katriona Keller; Alkomiet Hasan; Sebastian Dörfler; Thomas Schneider-Axmann; Ursula Hillmer-Vogel; William G Honer; Thomas G Schulze; Andree Niklas; Thomas Wobrock; Andrea Schmitt; Peter Falkai
Journal:  Schizophr Bull       Date:  2015-03-17       Impact factor: 9.306

8.  Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?

Authors:  Mandy Busse; Stefan Busse; Aye Mu Myint; Tomasz Gos; Henrik Dobrowolny; Ulf J Müller; Bernhard Bogerts; Hans-Gert Bernstein; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-20       Impact factor: 5.270

9.  Stochastic tractography study of Inferior Frontal Gyrus anatomical connectivity in schizophrenia.

Authors:  Marek Kubicki; Jorge L Alvarado; Carl-Fredrik Westin; David F Tate; Douglas Markant; Douglas P Terry; Thomas J Whitford; Julien De Siebenthal; Sylvain Bouix; Robert W McCarley; Ron Kikinis; Martha E Shenton
Journal:  Neuroimage       Date:  2011-01-21       Impact factor: 6.556

10.  Functional deficits in the extrastriate body area during observation of sports-related actions in schizophrenia.

Authors:  Hidehiko Takahashi; Motoichiro Kato; Takeshi Sassa; Tomohisa Shibuya; Michihiko Koeda; Noriaki Yahata; Masato Matsuura; Kunihiko Asai; Tetsuya Suhara; Yoshiro Okubo
Journal:  Schizophr Bull       Date:  2008-10-16       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.